Spanberger Launches 2020 Prescription Drug Survey, Invites Feedback & Personal Stories from Central Virginians

*Click here for photos from the Congresswoman’s recent in-district Healthcare Tour*

WASHINGTON, D.C. — U.S. Representative Abigail Spanberger today launched her 2020 Prescription Drug Survey to gather direct feedback from her constituents on the growing crisis of prescription drug costs. 

Since taking office last year, Spanberger has worked on multiple pieces of legislation aimed at reducing the high cost of prescription drugs for Central Virginia families, seniors, and those with chronic conditions. Her efforts include leading the bipartisan Public Disclosure of Drug Discounts Act, which passed 403 to 0 in the U.S. House, and passing the Lower Drug Costs Now Act, which would empower Medicare Part D to negotiate and fight for lower drug prices for beneficiaries.

“Across our ten counties, constituents of all ages come up to me and raise their concerns about the rising cost of prescription drugs. They’ve shared stories about rationing doses and making trade-offs with other expenses like groceries in order to afford their medication. This affordability crisis creates intense anxiety for so many members of our Central Virginia communities, and meaningful, bipartisan action in the House is long overdue,” said Spanberger. “Listening to the people I serve is a critical component of any legislative effort. As I continue to work on this issue in Washington, I want to hear more facts and experiences from Central Virginians. This firsthand input will help me better address our district’s concerns and build consensus among lawmakers on both sides of the aisle. I encourage Central Virginians to complete the three-minute survey, and I thank everyone for sharing their perspective. I look forward to reading the results.”

Throughout months of legislative work, Spanberger has regularly invited constituents in the Seventh District to share their stories and give direct input on the issue. In August, she convened a prescription drug roundtable in Henrico to hear from patients and discuss potential legislative solutions. In November 2019, she completed a two-day, nine-stop district healthcare tour across Central Virginia and concluded by hosting an open, community forum on prescription drug costs alongside AARP.

The 2020 Prescription Drug Survey is available under the Issues section of Spanberger’s website at


Spanberger has worked consistently throughout her first year in office to advance bipartisan legislation to address the staggering costs facing Central Virginians at the pharmacy counter.

In December 2019, she passed landmark legislation that would allow Medicare Part D to negotiate with manufacturers to lower drug prices for Virginia seniors. The Spanberger-cosponsored Lower Drug Costs Now Act would also strengthen Medicare benefits for basic needs like dental and vision, and reverse years of unfair prices hikes on medications that treat common conditions like diabetes.

Additionally, the Spanberger-cosponsored CREATES Act was signed into law by President Trump in December, after passing in the U.S. House with bipartisan support. The bill would crack down on the anti-competitive practices that pharmaceutical companies often use to prevent cheaper, generic medications from getting to market.

In April 2019, she introduced the Public Disclosure of Drug Discounts Act alongside U.S. Representatives Jodey Arrington (R-TX-19) and Brendan Boyle (D-PA-02). Her bill would increase accountability in the prescription drug industry by requiring pharmacy benefit managers to be more transparent about the potential role they play in driving up prices. Her bipartisan legislation passed in the U.S. House in October 2019 with 403 votes in support and none against.

And in October 2019, Spanberger introduced a bipartisan bill to level the playing field for makers of generic drugs and help get these more affordable options to consumers. She led the introduction of the Biologic Patent Transparency Act alongside U.S. Representative Tom Reed (R-NY-23).


Recent Posts

Feb 28, 2024

Spanberger Leads Virginia Lawmakers in Working to Protect $30 Internet Discount for Virginia Families, Fund Affordable Connectivity Program

The “Affordable Connectivity Program” Right Now Helps More than 455,000 Virginia Households Afford High-Speed Internet WASHINGTON, D.C. — U.S. Representative Abigail Spanberger today led members of the Virginia congressional delegation in a bipartisan effort urging the U.S. House Committee on Appropriations to extend funding for a key discount program that allows more Virginia families to […]

Feb 26, 2024
Womens' Issues

In Wake of Alabama Supreme Court Ruling, Spanberger Joins Bipartisan, Bicameral Effort to Protect Access to IVF

Congresswoman: “This Ruling Sets a Dangerous Precedent” WASHINGTON, D.C. — U.S. Representative Abigail Spanberger today backed bipartisan legislation to protect every American’s right to access in-vitro fertilization (IVF) following the Alabama Supreme Court’s ruling that frozen embryos are children under the law. On February 16, 2024, the Alabama Supreme Court ruled that frozen embryos — […]

Spanberger, Valadao Introduce Bipartisan Bill to Strengthen U.S. Voting Systems Against Foreign Attacks

U.S. Senate Version is Led by U.S. Senators Mark Warner & Susan Collins WASHINGTON, D.C. — U.S. Representatives Abigail Spanberger (D-VA-07) and David Valadao (R-CA-22) today introduced bipartisan legislation to strengthen the security of U.S. election infrastructure by requiring that voting systems undergo simulated attacks as part of their standard certification process. Given ongoing attempts […]